Abstract:Diabetes, a chronic disease characterized by hyperglycemia, is associated with significantly accelerated complications, including diabetic kidney disease (DKD), which increases morbidity and mortality. Hyperglycemia and other diabetes-related environmental factors such as overnutrition, sedentary lifestyles, and hyperlipidemia can induce epigenetic changes. Working alone or with genetic factors, these epigenetic changes that occur without alterations in the underlying DNA sequence, can alter the expression of pathophysiological genes and impair functions of associated target cells/organs, leading to diabetic complications like DKD. Notably, some hyperglycemia-induced epigenetic changes persist in target cells/tissues even after glucose normalization, leading to sustained complications despite glycemic control, so-called metabolic memory. Emerging evidence from in vitro and in vivo animal models and clinical trials with subjects with diabetes identified clear associations between metabolic memory and epigenetic changes including DNA methylation, histone modifications, chromatin structure, and noncoding RNAs at key loci. Targeting such persistent epigenetic changes and/or molecules regulated by them can serve as valuable opportunities to attenuate, or erase metabolic memory, which is crucial to prevent complication progression. Here, we review these cell/tissue-specific epigenetic changes identified to-date as related to diabetic complications, especially DKD, and the current status on targeting epigenetics to tackle metabolic memory. We also discuss limitations in current studies, including the need for more (epi)genome-wide studies, integrative analysis using multiple epigenetic marks and Omics datasets, and mechanistic evaluation of metabolic memory. Considering the tremendous technological advances in epigenomics, genetics, sequencing, and availability of genomic datasets from clinical cohorts, this field is likely to see considerable progress in the upcoming years.

Role of Histone Acetylation in the Development of Diabetic Retinopathy and the Metabolic Memory Phenomenon

Epigenetic Modification Ofsod2in the Development of Diabetic Retinopathy and in the Metabolic Memory: Role of Histone Methylation

Epigenetic Modifications of Nrf2-mediated Glutamate–cysteine Ligase: Implications for the Development of Diabetic Retinopathy and the Metabolic Memory Phenomenon Associated with Its Continued Progression

The Role of Epigenetic Modification in Diabetic Metabolic Memory

Acetylation of Retinal Histones in Diabetes Increases Inflammatory Proteins: EFFECTS OF MINOCYCLINE AND MANIPULATION OF HISTONE ACETYLTRANSFERASE (HAT) AND HISTONE DEACETYLASE (HDAC)

Metabolic Memory and Diabetic Retinopathy: Role of Inflammatory Mediators in Retinal Pericytes.

Histone HIST1H1C/H1.2 Regulates Autophagy in the Development of Diabetic Retinopathy

Epigenetic Changes in Mitochondrial Superoxide Dismutase in the Retina and the Development of Diabetic Retinopathy.

Metabolic memory: mechanisms and implications for diabetic retinopathy.

Histone H 1 . 2 regulates autophagy in the development of diabetic retinopathy

Metabolic Memory: Mechanisms and Implications for Diabetic Retinopathy

Epigenetic Modifications of Keap1 Regulate Its Interaction with the Protective Factor Nrf2 in the Development of Diabetic Retinopathy

Epigenetic Modifications and Potential New Treatment Targets in Diabetic Retinopathy

Novel histone post-translational modifications in diabetes and complications of diabetes: The underlying mechanisms and implications

Update: the role of epigenetics in the metabolic memory of diabetic complications

Acetylated Histone Modifications: Intersection of Diabetes and Atherosclerosis

Diabetic Retinopathy and Damage to Mitochondrial Structure and Transport Machinery.

High levels of glucose induce “metabolic memory” in cardiomyocyte via epigenetic histone H3 lysine 9 methylation

Impact of High Glucose and Proteasome Inhibitor MG132 on Histone H2A and H2B Ubiquitination in Rat Glomerular Mesangial Cells

Regulation of matrix metalloproteinase-9 by epigenetic modifications and the development of diabetic retinopathy.

Sirtuin 1-Mediated Cellular Metabolic Memory Of High Glucose Via The Lkb1/Ampk/Ros Pathway And Therapeutic Effects Of Metformin